Endy Widya Putranto

787 total citations
13 papers, 365 citations indexed

About

Endy Widya Putranto is a scholar working on Molecular Biology, Immunology and Clinical Biochemistry. According to data from OpenAlex, Endy Widya Putranto has authored 13 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Clinical Biochemistry. Recurrent topics in Endy Widya Putranto's work include S100 Proteins and Annexins (7 papers), Immune Response and Inflammation (5 papers) and Advanced Glycation End Products research (4 papers). Endy Widya Putranto is often cited by papers focused on S100 Proteins and Annexins (7 papers), Immune Response and Inflammation (5 papers) and Advanced Glycation End Products research (4 papers). Endy Widya Putranto collaborates with scholars based in Japan, Indonesia and Azerbaijan. Endy Widya Putranto's co-authors include Masakiyo Sakaguchi, Hitoshi Murata, I Made Winarsa Ruma, Rie Kinoshita, Yusuke Inoue, Nam-ho Huh, Ken-ichi Yamamoto, Junichiro Futami, Toshihiko Hibino and I Wayan Sumardika and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Investigative Dermatology and Bioorganic & Medicinal Chemistry.

In The Last Decade

Endy Widya Putranto

13 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Endy Widya Putranto Japan 11 228 95 65 61 53 13 365
Xin Fan China 12 183 0.8× 85 0.9× 91 1.4× 80 1.3× 23 0.4× 31 395
Shari L. Caplan United States 10 253 1.1× 24 0.3× 57 0.9× 97 1.6× 48 0.9× 12 431
Zhanchuan Ma China 13 161 0.7× 321 3.4× 78 1.2× 54 0.9× 13 0.2× 26 569
В. В. Соболев Russia 13 175 0.8× 241 2.5× 76 1.2× 83 1.4× 16 0.3× 56 438
Michael Scannell Ireland 6 263 1.2× 249 2.6× 36 0.6× 60 1.0× 15 0.3× 8 517
Dae‐Weon Park South Korea 13 172 0.8× 153 1.6× 42 0.6× 54 0.9× 10 0.2× 16 371
Alona A. Merkulova United States 3 139 0.6× 146 1.5× 27 0.4× 46 0.8× 10 0.2× 5 361
Xingsong Tian China 13 309 1.4× 65 0.7× 98 1.5× 225 3.7× 22 0.4× 21 488

Countries citing papers authored by Endy Widya Putranto

Since Specialization
Citations

This map shows the geographic impact of Endy Widya Putranto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Endy Widya Putranto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Endy Widya Putranto more than expected).

Fields of papers citing papers by Endy Widya Putranto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Endy Widya Putranto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Endy Widya Putranto. The network helps show where Endy Widya Putranto may publish in the future.

Co-authorship network of co-authors of Endy Widya Putranto

This figure shows the co-authorship network connecting the top 25 collaborators of Endy Widya Putranto. A scholar is included among the top collaborators of Endy Widya Putranto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Endy Widya Putranto. Endy Widya Putranto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Saito, Ken, Masakiyo Sakaguchi, Satoshi Maruyama, et al.. (2018). Stromal mesenchymal stem cells facilitate pancreatic cancer progression by regulating specific secretory molecules through mutual cellular interaction. Journal of Cancer. 9(16). 2916–2929. 35 indexed citations
2.
Putranto, Endy Widya, Rie Kinoshita, Masami Watanabe, et al.. (2017). Expression of tumor suppressor REIC/Dkk-3 by a newly improved adenovirus vector with insertion of a hTERT promoter at the 3′-side of the transgene. Oncology Letters. 14(1). 1041–1048. 1 indexed citations
3.
Sumardika, I Wayan, Youyi Chen, Eisaku Kondo, et al.. (2017). -1,3-Galactosyl-O-Glycosyl-Glycoprotein -1,6-N-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 26(3). 431–444. 24 indexed citations
4.
Sakaguchi, Masakiyo, Rie Kinoshita, Endy Widya Putranto, et al.. (2017). Signal Diversity of Receptor for Advanced Glycation End Products.. PubMed. 71(6). 459–465. 27 indexed citations
5.
Sakaguchi, Masakiyo, Mami Yamamoto, Tatsuo Maeda, et al.. (2016). Identification of an S100A8 Receptor Neuroplastin-β and its Heterodimer Formation with EMMPRIN. Journal of Investigative Dermatology. 136(11). 2240–2250. 37 indexed citations
6.
Ruma, I Made Winarsa, Endy Widya Putranto, Eisaku Kondo, et al.. (2016). MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding. Clinical & Experimental Metastasis. 33(6). 609–627. 53 indexed citations
7.
Futami, Junichiro, et al.. (2016). An efficient method for the preparation of preferentially heterodimerized recombinant S100A8/A9 coexpressed in Escherichia coli. Biochemistry and Biophysics Reports. 6. 94–100. 11 indexed citations
8.
Ruma, I Made Winarsa, Endy Widya Putranto, Eisaku Kondo, et al.. (2014). Extract of Cordyceps militaris inhibits angiogenesis and suppresses tumor growth of human malignant melanoma cells. International Journal of Oncology. 45(1). 209–218. 34 indexed citations
9.
Sakaguchi, Masakiyo, Hitoshi Murata, Yumi Aoyama, et al.. (2014). DNAX-activating Protein 10 (DAP10) Membrane Adaptor Associates with Receptor for Advanced Glycation End Products (RAGE) and Modulates the RAGE-triggered Signaling Pathway in Human Keratinocytes. Journal of Biological Chemistry. 289(34). 23389–23402. 30 indexed citations
10.
Sakaguchi, Masakiyo, Masami Watanabe, Rie Kinoshita, et al.. (2014). Dramatic Increase in Expression of a Transgene by Insertion of Promoters Downstream of the Cargo Gene. Molecular Biotechnology. 56(7). 621–630. 48 indexed citations
11.
Ōhashi, Masao, Takuji Oyama, Endy Widya Putranto, et al.. (2013). Design and synthesis of a series of α-benzyl phenylpropanoic acid-type peroxisome proliferator-activated receptor (PPAR) gamma partial agonists with improved aqueous solubility. Bioorganic & Medicinal Chemistry. 21(8). 2319–2332. 28 indexed citations
12.
Putranto, Endy Widya, Hitoshi Murata, Kenichi Yamamoto, et al.. (2013). Inhibition of RAGE signaling through the intracellular delivery of inhibitor peptides by PEI cationization. International Journal of Molecular Medicine. 32(4). 938–944. 10 indexed citations
13.
Yamamoto, Ken-ichi, Hitoshi Murata, Endy Widya Putranto, et al.. (2012). DOCK7 is a critical regulator of the RAGE-Cdc42 signaling axis that induces formation of dendritic pseudopodia in human cancer cells. Oncology Reports. 29(3). 1073–1079. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026